The role of maternal PCOS PRS in the associations between child PCOS PRS and childhood outcomes in ALSPAC
Association of the child PCOS PRS vs child PCOS PRS residuala and cardiometabolic outcomes . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Time periods . | n . | BMI Z-score . | n . | Obesity . | n . | Fat mass index . | ||||||
β . | 95% CI . | P . | . | OR . | 95% CI . | P . | . | β . | 95% CI . | P . | ||
Early childhood | 588 | 588 | — | |||||||||
Child PRS | .04 | −0.04, 0.12 | .3 | 1.20 | 0.89, 1.63 | .2 | — | — | — | |||
Child PRS residual | .05 | −0.035, 0.139 | .2 | 1.31 | 0.93, 1.85 | .1 | — | — | — | |||
Midchildhood | 3861 | 3861 | 4156 | |||||||||
Child PRS | .07 | 0.04, 0.11 | 7 × 10−6 | 1.22 | 1.11, 1.36 | 9 × 10−5 | .19 | 0.12, 0.26 | 9 × 10−8 | |||
Child PRS residual | .06 | 0.02, 0.10 | .002 | 1.15 | 1.03, 1.30 | .02 | .13 | 0.05, 0.21 | .002 | |||
Early adolescence | 3829 | 3829 | 3782 | |||||||||
Child PRS | .08 | 0.04, 0.11 | 4 × 10−5 | 1.14 | 1.04, 1.26 | .007 | .18 | 0.10, 0.27 | 6 × 10−5 | |||
Child PRS residual | .07 | 0.02, 0.11 | .002 | 1.13 | 1.01, 1.26 | .03 | .15 | 0.04, 0.25 | .006 | |||
Late adolescence | 2966 | 2966 | 2858 | |||||||||
Child PRS | .06 | 0.01, 0.10 | .009 | 1.16 | 1.04, 1.29 | .007 | .18 | 0.06, 0.30 | .003 | |||
Child PRS residual | .05 | 0.00, 0.10 | .052 | 1.13 | 1.00, 1.28 | .04 | .14 | 0.00, 0.28 | .06 | |||
Association of the child PCOS PRS vs child PCOS PRS residuala and growth outcomes | ||||||||||||
Age at pubarche n = 2421 | Age at peak height velocity n = 3543 | |||||||||||
Child PRS | −1.04 | −1.73, −0.35 | .003 | −0.68 | −1.03, −0.32 | .0002 | ||||||
Child PRS residual | −0.90 | −1.71, −0.09 | .03 | −0.63 | −1.03, −0.22 | .003 |
Association of the child PCOS PRS vs child PCOS PRS residuala and cardiometabolic outcomes . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Time periods . | n . | BMI Z-score . | n . | Obesity . | n . | Fat mass index . | ||||||
β . | 95% CI . | P . | . | OR . | 95% CI . | P . | . | β . | 95% CI . | P . | ||
Early childhood | 588 | 588 | — | |||||||||
Child PRS | .04 | −0.04, 0.12 | .3 | 1.20 | 0.89, 1.63 | .2 | — | — | — | |||
Child PRS residual | .05 | −0.035, 0.139 | .2 | 1.31 | 0.93, 1.85 | .1 | — | — | — | |||
Midchildhood | 3861 | 3861 | 4156 | |||||||||
Child PRS | .07 | 0.04, 0.11 | 7 × 10−6 | 1.22 | 1.11, 1.36 | 9 × 10−5 | .19 | 0.12, 0.26 | 9 × 10−8 | |||
Child PRS residual | .06 | 0.02, 0.10 | .002 | 1.15 | 1.03, 1.30 | .02 | .13 | 0.05, 0.21 | .002 | |||
Early adolescence | 3829 | 3829 | 3782 | |||||||||
Child PRS | .08 | 0.04, 0.11 | 4 × 10−5 | 1.14 | 1.04, 1.26 | .007 | .18 | 0.10, 0.27 | 6 × 10−5 | |||
Child PRS residual | .07 | 0.02, 0.11 | .002 | 1.13 | 1.01, 1.26 | .03 | .15 | 0.04, 0.25 | .006 | |||
Late adolescence | 2966 | 2966 | 2858 | |||||||||
Child PRS | .06 | 0.01, 0.10 | .009 | 1.16 | 1.04, 1.29 | .007 | .18 | 0.06, 0.30 | .003 | |||
Child PRS residual | .05 | 0.00, 0.10 | .052 | 1.13 | 1.00, 1.28 | .04 | .14 | 0.00, 0.28 | .06 | |||
Association of the child PCOS PRS vs child PCOS PRS residuala and growth outcomes | ||||||||||||
Age at pubarche n = 2421 | Age at peak height velocity n = 3543 | |||||||||||
Child PRS | −1.04 | −1.73, −0.35 | .003 | −0.68 | −1.03, −0.32 | .0002 | ||||||
Child PRS residual | −0.90 | −1.71, −0.09 | .03 | −0.63 | −1.03, −0.22 | .003 |
Abbreviations: BMI, body mass index; n, number of mother–child pairs; PCOS, polycystic ovary syndrome; PRS, polygenic risk score.
aAdjusted for maternal PCOS PRS.
The role of maternal PCOS PRS in the associations between child PCOS PRS and childhood outcomes in ALSPAC
Association of the child PCOS PRS vs child PCOS PRS residuala and cardiometabolic outcomes . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Time periods . | n . | BMI Z-score . | n . | Obesity . | n . | Fat mass index . | ||||||
β . | 95% CI . | P . | . | OR . | 95% CI . | P . | . | β . | 95% CI . | P . | ||
Early childhood | 588 | 588 | — | |||||||||
Child PRS | .04 | −0.04, 0.12 | .3 | 1.20 | 0.89, 1.63 | .2 | — | — | — | |||
Child PRS residual | .05 | −0.035, 0.139 | .2 | 1.31 | 0.93, 1.85 | .1 | — | — | — | |||
Midchildhood | 3861 | 3861 | 4156 | |||||||||
Child PRS | .07 | 0.04, 0.11 | 7 × 10−6 | 1.22 | 1.11, 1.36 | 9 × 10−5 | .19 | 0.12, 0.26 | 9 × 10−8 | |||
Child PRS residual | .06 | 0.02, 0.10 | .002 | 1.15 | 1.03, 1.30 | .02 | .13 | 0.05, 0.21 | .002 | |||
Early adolescence | 3829 | 3829 | 3782 | |||||||||
Child PRS | .08 | 0.04, 0.11 | 4 × 10−5 | 1.14 | 1.04, 1.26 | .007 | .18 | 0.10, 0.27 | 6 × 10−5 | |||
Child PRS residual | .07 | 0.02, 0.11 | .002 | 1.13 | 1.01, 1.26 | .03 | .15 | 0.04, 0.25 | .006 | |||
Late adolescence | 2966 | 2966 | 2858 | |||||||||
Child PRS | .06 | 0.01, 0.10 | .009 | 1.16 | 1.04, 1.29 | .007 | .18 | 0.06, 0.30 | .003 | |||
Child PRS residual | .05 | 0.00, 0.10 | .052 | 1.13 | 1.00, 1.28 | .04 | .14 | 0.00, 0.28 | .06 | |||
Association of the child PCOS PRS vs child PCOS PRS residuala and growth outcomes | ||||||||||||
Age at pubarche n = 2421 | Age at peak height velocity n = 3543 | |||||||||||
Child PRS | −1.04 | −1.73, −0.35 | .003 | −0.68 | −1.03, −0.32 | .0002 | ||||||
Child PRS residual | −0.90 | −1.71, −0.09 | .03 | −0.63 | −1.03, −0.22 | .003 |
Association of the child PCOS PRS vs child PCOS PRS residuala and cardiometabolic outcomes . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Time periods . | n . | BMI Z-score . | n . | Obesity . | n . | Fat mass index . | ||||||
β . | 95% CI . | P . | . | OR . | 95% CI . | P . | . | β . | 95% CI . | P . | ||
Early childhood | 588 | 588 | — | |||||||||
Child PRS | .04 | −0.04, 0.12 | .3 | 1.20 | 0.89, 1.63 | .2 | — | — | — | |||
Child PRS residual | .05 | −0.035, 0.139 | .2 | 1.31 | 0.93, 1.85 | .1 | — | — | — | |||
Midchildhood | 3861 | 3861 | 4156 | |||||||||
Child PRS | .07 | 0.04, 0.11 | 7 × 10−6 | 1.22 | 1.11, 1.36 | 9 × 10−5 | .19 | 0.12, 0.26 | 9 × 10−8 | |||
Child PRS residual | .06 | 0.02, 0.10 | .002 | 1.15 | 1.03, 1.30 | .02 | .13 | 0.05, 0.21 | .002 | |||
Early adolescence | 3829 | 3829 | 3782 | |||||||||
Child PRS | .08 | 0.04, 0.11 | 4 × 10−5 | 1.14 | 1.04, 1.26 | .007 | .18 | 0.10, 0.27 | 6 × 10−5 | |||
Child PRS residual | .07 | 0.02, 0.11 | .002 | 1.13 | 1.01, 1.26 | .03 | .15 | 0.04, 0.25 | .006 | |||
Late adolescence | 2966 | 2966 | 2858 | |||||||||
Child PRS | .06 | 0.01, 0.10 | .009 | 1.16 | 1.04, 1.29 | .007 | .18 | 0.06, 0.30 | .003 | |||
Child PRS residual | .05 | 0.00, 0.10 | .052 | 1.13 | 1.00, 1.28 | .04 | .14 | 0.00, 0.28 | .06 | |||
Association of the child PCOS PRS vs child PCOS PRS residuala and growth outcomes | ||||||||||||
Age at pubarche n = 2421 | Age at peak height velocity n = 3543 | |||||||||||
Child PRS | −1.04 | −1.73, −0.35 | .003 | −0.68 | −1.03, −0.32 | .0002 | ||||||
Child PRS residual | −0.90 | −1.71, −0.09 | .03 | −0.63 | −1.03, −0.22 | .003 |
Abbreviations: BMI, body mass index; n, number of mother–child pairs; PCOS, polycystic ovary syndrome; PRS, polygenic risk score.
aAdjusted for maternal PCOS PRS.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.